Kangmei Pharmaceutical Co., Ltd. Related Transaction Data Statistics System (December 2025)
Kangmei Pharmaceutical Co., Ltd.
Related party transaction data statistics system
Chapter 1 General Provisions
Article 1 In order to fully protect the legitimate rights and interests of Kangmei Pharmaceutical Co., Ltd. (hereinafter referred to as the "Company") and all shareholders, ensure the fairness of the company's related transactions, ensure that the company's related transactions do not harm the interests of the company and all shareholders, control the risks of related transactions, and make the company's related transactions comply with the principles of fairness, justice and openness, in accordance with the "Company Law of the People's Republic of China", "Securities Law of the People's Republic of China", "Stock Listing Rules of the Shanghai Stock Exchange", "Self-discipline Supervision Guidelines for Listed Companies of the Shanghai Stock Exchange" No. 5 - Transactions and Related Party Transactions" and other laws, regulations, normative documents and the relevant provisions of the "Articles of Association", combined with the company's actual situation and management requirements, formulate a statistical system for related transaction data.
Article 2 This system is applicable to all relevant units of the company, with full participation and comprehensive coverage, and the whole process of related transaction data (including all related transactions and related party lists) is recorded, statistically updated, information disclosed and archived in a timely manner.
Article 3 Management Principles
(1) Principle of legal compliance: The statistics of related party transaction data shall be carried out in compliance with relevant regulatory rules and the Articles of Association and other relevant provisions.
(2) Principle of objectivity: The authenticity and accuracy of statistical data are the foundation of statistical value. During the statistical process, statistical staff must respect objective facts, be free from bias, and be free from external influences and constraints. They must complete statistics truly and ensure that all data can reflect the actual situation.
(3) Unification principle: The company and all relevant units shall follow the requirements of unified standards when implementing this system, and must complete the data collection of related transaction statistics in accordance with the requirements of this system.
Chapter 2 Responsibilities Statement
Article 4 The responsibilities of each relevant unit of the company include:
(1) Responsible for daily follow-up of related-party transactions initiated by this department, recording the transaction process and transaction results.
(2) Responsible for assisting the Securities Affairs Department in completing the data collection of regular related-party transaction statistics.
(3) In accordance with the provisions of the company's "Kangmei Pharmaceutical Co., Ltd. Related Transaction Management System", be responsible for identifying related transactions (including all related transactions and related parties) for all transactions occurring in the department, and submit related transaction information to the Securities Affairs Department in a timely manner.
Article 5 The responsibilities of the Finance Department include:
(1) According to the related party directory provided by the Securities Affairs Department and the company's "Kangmei Pharmaceutical Co., Ltd. Related Transaction Management System", be responsible for accounting for related transactions and ensure the accuracy of related transaction data.
(2) Regularly complete related-party transaction statistics and prepare related-party transaction data statistics tables.
Article 6 The responsibilities of the Securities Affairs Department include:
(1) Lead the organization of regular related-party transaction data statistics, coordinate with relevant units and the headquarters finance department to summarize the company's related-party transaction data, and initially prepare related-party transaction data statistics tables.
(2) Do a good job in related transaction risk reporting and information disclosure.
(3) Do a good job in archiving related transaction data statistics.
Article 7 The board of directors and shareholders' meeting shall review and approve related statistical data that meet the corresponding standards in accordance with the "Related Transaction Management System of Kangmei Pharmaceutical Co., Ltd."
Chapter 3 Specific Implementation Procedures for Related Party Transaction Data Statistics
Section 1 Organization of Related Party Transaction Data Statistics
Article 8 The Securities Affairs Department regularly organizes statistical work on related party transaction data, and all relevant units and the Headquarters Finance Department are responsible for assisting in completing the statistical work.
Article 9 The Securities Affairs Department shall organize related transaction data statistics work after the end of each quarter, and conduct statistics on all related transactions that occurred at the headquarters and branch companies in the previous quarter. The statistical work must be completed before the 15th of the first month of the new quarter.
Article 10 The Securities Affairs Department shall organize related transaction data statistics after the end of each year, and conduct statistical work on all related transactions that occurred at the company's headquarters and branch companies in the previous year. At the same time, it must organize past related transactions and improve related transaction data.
Section 2: Development of statistics on related party transaction data
Article 11 During the process of related transactions, in addition to submitting related transactions that meet the approval standards for approval through the company's OA system process in accordance with the company's "Kangmei Pharmaceutical Co., Ltd. Related Transaction Management System", all relevant units should also track and record the transaction process and transaction results in a timely manner. If related-party transactions are expected to increase, each relevant unit must supplement the updated related-party transaction data to the original approval process and submit it to the Headquarters Finance Department and Securities Affairs Department so that the Securities Affairs Department can update and archive the data in a timely manner.
Article 12 During the regular statistical work organized by the Securities Affairs Department, all relevant units shall identify related transactions for all transactions occurring in the department in accordance with the company's "Related Transaction Management System of Kangmei Pharmaceutical Co., Ltd.", including identification of related transactions and related parties, and timely register and update changed data. In accordance with the statistical work arrangement, the department's updated estimated amount of related-party transactions will be submitted to the Securities Affairs Department on time through the company's OA system process.
Article 13 The Finance Department shall sort out and summarize the related transaction data every month in accordance with the statistical work arrangement. According to the provisions of the company's "Related Transaction Management System of Kangmei Pharmaceutical Co., Ltd.", prepare a statistical table of related transaction data and submit it to the Securities Affairs Department.
Section 3 Approval and Archiving of Related Party Transaction Statistics
Article 14 The Securities Affairs Department organizes statistical work on related-party transaction data from time to time, and submits the completed related-party transaction data to the board of directors for approval based on the related-party transaction statistical data submitted by relevant units and the Finance Department.
Article 15 The Securities Affairs Department shall promptly complete information disclosure and archive relevant materials in accordance with regulations.
Chapter 6 Supplementary Provisions
Article 16 This system guides and restricts matters involving the company's related transactions.
Article 17 This system is bound by Chinese laws, regulations, normative documents and the Articles of Association. If there is any conflict, Chinese laws, regulations, normative documents and the Articles of Association shall prevail. This system will be adjusted in time.
Article 18 For matters not listed in this system, the Articles of Association shall prevail.
Article 19 This system is formulated by the board of directors and will take effect from the date of review and approval by the company's shareholders' meeting. The same applies when it is revised.